CORONA Remedies: Q1 vs Q2 vs Q3 FY26 – Financial performance & QoQ growth
DBT Bureau Pune, 3 Feb 2026 Despite a sequential dip in revenue during Q3 FY26, CORONA Remedies delivered strong margin expansion and profit growth, with PAT rising 6.2% QoQ and ...
















